Treatment Resistant Depression
Find Hope with SPRAVATO® Treatment
Ketamine therapy with SPRAVATO is a breakthrough option for adults with treatment-resistant depression.
What is SPRAVATO?
SPRAVATO is an FDA-approved prescription nasal spray containing esketamine.
It is an FDA medication that treats adults with depression and acute suicidal thoughts or actions. Treatment is administered only at certified healthcare facilities.
How Ketamine Therapy with Spravato Works
Unlike traditional antidepressants that primarily target serotonin, ketamine works through the brain’s glutamate system, which plays a vital role in mood, learning, memory, and communication between brain cells. It is believed that ketamine promotes the brain’s ability to make new pathways or neuroplasticity.
SPRAVATO® Offers a Different Approach. Serenity Makes the Experience Personal.
- Comfortable, supportive environment where patients receive careful monitoring
- Insurance Approvals in as Little as One Week
- One analysis found about a 52% response rate at 24 hours after treatment
- Ketamine-based treatments have shown significant antidepressant effects, with some studies reporting high response rates for depression